2008/897/EC: Commission Decision of 28 November 2008 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2009 and following years (notified under document number C(2008) 7415)
Date: 2008-11-28
Institutions: European Commission
Subjects: animal disease, distribution of EU funding, health risk, veterinary inspection, zoonosis

2.12.2008

EN

Official Journal of the European Union

L 322/39

COMMISSION DECISION

of 28 November 2008

approving annual and multi-annual programmes and the financial contribution from the Community
for the eradication, control and monitoring of certain animal diseases and zoonoses presented by
the Member States for 2009 and following years

(notified under document number C(2008) 7415)

(2008/897/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(5)

(6)

(7)

(8)

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular
Article 24(5) thereof,

Whereas:

(1)

(2)

(3)

(4)

90/424/EEC lays

Decision
procedures
governing the Community's financial contribution for
programmes for the eradication, control and monitoring
of animal diseases and zoonoses.

down

the

In addition, Article 24(1) of Decision 90/424/EEC
provides that a Community financial measure is to be
introduced to reimburse the expenditure incurred by the
Member States for the financing of national programmes
for the eradication, control and monitoring of the animal
diseases and zoonoses
listed in the Annex to that
Decision.

Council Decision 2006/965/EC of 19 December 2006
amending Decision 90/424/EEC on expenditure in the
veterinary field (2) replaced Article 24 to that Decision
by a new provision. By way of transitional measures,
Decision 2006/965/EC provided that programmes for
enzootic bovine leucosis and for Aujeszky's disease
could continue to be funded until 31 December 2010.

down

criteria

Community

Commission Decision 2008/341/EC of 25 April 2008
national
laying
programmes for the eradication, control and monitoring
of certain animal diseases and zoonoses (3) provides that
in order to be approved under the measures provided for
in Article 24(1) of Decision 90/424/EEC, programmes
submitted by the Member States must meet the criteria
set out in the Annex to Decision 2008/341/EC.

for

the

Regulation (EC) No 999/2001 of
European
Parliament and of the Council of 22 May 2001 laying
down rules for the prevention, control and eradication of
spongiform encephalopathies (4),
certain transmissible
provides
by
Member States for transmissible spongiform encephalo­
pathies (TSEs) in bovine, ovine and caprine animals.

annual monitoring

programmes

for

of

the

control

to be carried out

Council Directive 2005/94/EC of 20 December 2005 on
avian
for
Community measures
influenza (5) also provides for surveillance programmes
by Member States
in respect of
poultry and wild birds in order to contribute, inter alia,
on the basis of regularly updated risk assessments, to the
knowledge on the threats posed by the wild birds in
relation to any influenza virus of avian origin in birds.
Those annual programmes, and their
for
monitoring should also be approved.

financing,

have

States

submitted

the
to
Certain Member
Commission annual programmes for
the eradication,
control and monitoring of animal diseases, programmes
of checks aimed at
the prevention of zoonoses, and
annual monitoring programmes for the eradication and
monitoring of certain TSEs for which they wish to
receive a financial contribution from the Community.

In 2008, certain multi-annual programmes submitted by
Member States for the eradication, control and moni­
toring of
the animal diseases were approved under
Commission Decision 2007/782/EC (6). The commitment
of the expenditure for those multi-annual programmes
was
adopted in accordance with Article 76(3) of
Council Regulation (EC, Euratom) No 1605/2002 of
25 June 2002 on the Financial Regulation applicable to
the general budget of the European Union. (7). The first
budget commitment for those programmes was made
annual
after
commitment should be made by the Commission in
function of
the programme for the
previous year, on the basis of a decision to grant a
contribution referred to in Article 24(5) of Decision
90/424/EEC.

the execution of

subsequent

approval.

Each

their

(1) OJ L 224, 18.8.1990, p. 19.
(2) OJ L 397, 30.12.2006, p. 22.
(3) OJ L 115, 29.4.2008, p. 44.

(4) OJ L 147, 31.5.2001, p. 1.
(5) OJ L 10, 14.1.2006, p. 16.
(6) OJ L 314, 1.12.2007, p. 29.
(7) OJ L 248, 16.9.2002, p. 1.

L 322/40

EN

Official Journal of the European Union

2.12.2008

(9)

(10)

(11)

year

as well

(second)

The Commission has assessed the annual programmes
submitted by the Member States,
the
subsequent
the multi-annual
programmes approved in 2008, from both the veterinary
and the financial point of view. Those programmes were
found to comply with relevant Community veterinary
legislation and in particular with the criteria set out in
Decision 2008/341/EC.

of

as

In the light of the importance of the annual and multi-
annual programmes for the achievement of Community
objectives in the field of animal and public health, as well
as the obligatory application in all Member States in the
case of the TSE and avian influenza programmes,
it is
appropriate to fix the appropriate rate of financial contri­
bution of the Community to reimburse the costs to be
incurred by the Member States concerned for
the
measures
referred to in this Decision up to a
maximum amount for each programme.

Council Directive 2006/88/EC of 24 October 2006 on
animal health requirements for aquaculture animals and
products thereof, and on the prevention and control of
certain diseases
that
Member States known to be infected by one or more
of the diseases listed in Part II of Annex IV to that
Directive should draw up eradication programmes for
those diseases.

in aquatic animals (1) provides

are

the

by
that Regulation provides

(12) Article 17 of Council Regulation (EC) No 1198/2006 of
27 July 2006 on the European Fisheries Fund (2) provides
that Member States
to draw up operational
programmes to implement the policies and priorities to
Fund.
be
co-financed
the
Article 32 of
that
Community may contribute to the financing of
the
control and eradication of diseases in aquaculture under
the terms of Decision 90/424/EEC. Pursuant to Decision
90/424/EEC, Member States may allocate funds within
those operational programmes for the eradication of
the diseases in aquaculture animals referred to in the
Annex to Decision 90/424/EEC.

European Fisheries

(13)

Certain Member States have drawn up multi-annual
programmes for the eradication of certain diseases in
aquatic animals,
listed both in Part II of Annex IV to
Directive 2006/88/EC and in the Annex to Decision
90/424/EEC. Those programmes have been technically
assessed by the Commission and should therefore be
approved.

(14)

For the sake of better management, more efficient use of
Community funds and improved transparency, it is also
necessary to fix for each programme (except for multi-
annual programmes for the eradication of certain diseases
in aquatic animals for which the financial contribution
will be fixed after their technical approval), where appro­
priate, average cost to be reimbursed to the Member
States for certain costs, such as the tests used in the
Member States and compensation to owners for their
losses due to the slaughter or culling of animals.

(15) Under Council Regulation (EC) No 1290/2005 of
21 June 2005 on the financing of the common agri­
cultural policy (3), programmes for the eradication and
control of animal diseases are to be financed under the
European Agricultural Guarantee Fund. For
financial
control purposes, Articles 9, 36 and 37 of that Regu­
lation are to apply.

(16)

(17)

(18)

The financial contribution from the Community should
the actions
be granted subject
and that
planned are
the
competent authorities supply all
the necessary infor­
mation within the time limits laid down in this Decision.

to the condition that
carried out

efficiently

a

by

for

financial

contribution

For reasons of administrative efficiency all expenditure
the
submitted
Community should be expressed in euro. In accordance
with Regulation (EC) No 1290/2005, the conversion rate
for expenditure in a currency other than the euro should
be the most recent exchange rate set by the European
Central Bank prior to the first day of the month in which
the application is
submitted by the Member State
concerned.

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

HAS ADOPTED THIS DECISION:

CHAPTER I

ANNUAL PROGRAMMES

Article 1

Bovine brucellosis

The programmes for the eradication of bovine brucellosis
1.
submitted by Ireland, Spain, Italy, Malta, Cyprus, Portugal and
the United Kingdom are hereby approved for the period from
1 January 2009 to 31 December 2009.

(1) OJ L 328, 24.11.2006, p. 14.
(2) OJ L 223, 15.8.2006, p. 1.

(3) OJ L 209, 11.8.2005, p. 1.

2.12.2008

EN

Official Journal of the European Union

L 322/41

The financial contribution by the Community shall be at
2.
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
laboratory tests, the compensation to owners for the value of
their animals slaughtered subject to those programmes and the
purchase of vaccine doses, and shall not exceed:

(a) EUR 1 100 000 for Ireland;

(b) EUR 3 000 000 for Spain;

(c) EUR 5 000 000 for Italy;

(d) EUR 77 000 for Cyprus;

(e) EUR 20 000 for Malta;

(f) EUR 1 400 000 for Portugal;

(g) EUR 2 000 000 for the United Kingdom.

owners for the value of their animals slaughtered subject to
those programmes, and shall not exceed:

(a) EUR 2 000 000 for Ireland;

(b) EUR 5 000 000 for Spain;

(c) EUR 2 700 000 for Italy;

(d) EUR 1 100 000 for Poland;

(e) EUR 1 000 000 for Portugal.

The maximum of

3.
the costs to be reimbursed to the
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

(a) for a tuberculin test

EUR 1 per test;

(b) for a gamma-interferon test

EUR 5 per test;

The maximum of

3.
the costs to be reimbursed to the
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

(c) for animals slaughtered

EUR 375 per animal.

(a) for a rose bengal test

EUR 0,2 per test;

Ovine and caprine brucellosis

Article 3

(b) for a SAT test

EUR 0,2 per test;

(c) for a complement fixation test

EUR 0,4 per test;

(d) for an ELISA test

EUR 1 per test;

(e) for animals slaughtered

EUR 375 per animal.

The programmes for the eradication of ovine and caprine
1.
brucellosis
Italy, Cyprus and
Portugal are hereby approved for the period from 1 January
2009 to 31 December 2009.

submitted by Greece, Spain,

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the purchase of vaccines,
the cost of carrying out laboratory tests and the compensation
to owners for the value of their animals slaughtered subject to
those programmes, and shall not exceed:

Article 2

Bovine tuberculosis

The programmes for the eradication of bovine tuber­
1.
culosis submitted by Ireland, Spain, Italy, Poland and Portugal
are hereby approved for the period from 1 January 2009 to
31 December 2009.

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the costs of carrying out
tuberculin and gamma-interferon tests and the compensation to

(a) EUR 250 000 for Greece;

(b) EUR 4 500 000 for Spain;

(c) EUR 4 000 000 for Italy;

(d) EUR 75 000 for Cyprus;

(e) EUR 1 100 000 for Portugal.

L 322/42

EN

Official Journal of the European Union

2.12.2008

The maximum of

the costs to be reimbursed to the
3.
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

(h) EUR 50 000 for Greece;

(i)

EUR 16 100 000 for Spain;

(a) for a rose bengal test

EUR 0,2 per test;

(j)

EUR 19 100 000 for France;

(b) for a complement fixation test EUR 0,4 per test;

(c) for animals slaughtered

EUR 50 per animal.

(k) EUR 9 000 000 for Italy;

(l)

EUR 70 000 for Latvia;

(m) EUR 50 000 for Lithuania;

Article 4

(n) EUR 220 000 for Luxembourg;

Bluetongue in endemic or high risk areas

1.
The programmes for the eradication and monitoring of
bluetongue submitted by Belgium, Bulgaria, the Czech Republic,
Ireland, Greece, Spain, France,
Denmark, Germany, Estonia,
Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta,
the
Netherlands, Austria, Poland, Portugal, Romania, Slovenia,
Finland and Sweden are hereby approved for the period from
1 January 2009 to 31 December 2009.

(o) EUR 500 000 for Hungary;

(p) EUR 5 000 for Malta;

(q) EUR 2 100 000 for the Netherlands;

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out the
laboratory tests for virological, serological and entomological
surveillance and the purchase of traps and vaccines, and shall
not exceed:

(a) EUR 1 200 000 for Belgium;

(b) EUR 5 000 for Bulgaria;

(c) EUR 790 000 for the Czech Republic;

(d) EUR 840 000 for Denmark;

(e) EUR 4 100 000 for Germany;

(f)

EUR 10 000 for Estonia;

(r)

EUR 1 500 000 for Austria;

(s) EUR 500 000 for Poland;

(t)

EUR 3 200 000 for Portugal;

(u) EUR 250 000 for Romania;

(v) EUR 250 000 for Slovenia;

(w) EUR 50 000 for Finland;

(x) EUR 370 000 for Sweden.

The maximum of

3.
the costs to be reimbursed to the
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

(a)

for an ELISA test EUR 2,5 per test;

(b) for a PCR test EUR 10 per test;

(g) EUR 1 000 000 for Ireland;

(c) For vaccine purchase EUR 0,3 per dose.

2.12.2008

EN

Official Journal of the European Union

L 322/43

Article 5

(m) EUR 270 000 for Latvia;

Salmonellosis (zoonotic salmonella) in breeding, laying and
broiler flocks of Gallus gallus

The programmes for

the control of certain zoonotic
1.
laying and broiler flocks of Gallus
salmonella in breeding,
the Czech Republic,
gallus submitted by Belgium, Bulgaria,
Ireland, Greece, Spain, France,
Denmark, Estonia, Germany,
Italy, Cyprus,
the
Netherlands, Austria, Poland, Portugal, Romania, Slovakia,
Slovenia and the United Kingdom are hereby approved for
the period from 1 January 2009 to 31 December 2009.

Luxembourg, Hungary, Malta,

Latvia,

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
bacteriological and serotyping tests in the framework of official
sampling, the compensation to owners for the value of the birds
culled and of the destroyed eggs, the purchase of vaccine doses
and the laboratory tests to verify the efficiency of disinfection
and shall not exceed:

(a) EUR 850 000 for Belgium;

(b) EUR 30 000 for Bulgaria;

(n) EUR 16 000 for Luxembourg;

(o) EUR 1 450 000 for Hungary;

(p) EUR 110 000 for Malta;

(q) EUR 1 700 000 for the Netherlands;

(r)

EUR 525 000 for Austria;

(s) EUR 1 550 000 for Poland;

(t)

EUR 500 000 for Portugal;

(u) EUR 450 000 for Romania;

(v) EUR 625 000 for Slovakia;

(w) EUR 25 000 for Slovenia;

(c) EUR 1 400 000 for the Czech Republic;

(x) EUR 20 000 for the United Kingdom.

(d) EUR 75 000 for Denmark;

(e) EUR 25 000 for Estonia;

(f)

EUR 600 000 for Germany;

(g) EUR 40 000 for Ireland;

(h) EUR 550 000 for Greece;

(i)

EUR 4 750 000 for Spain;

(j)

EUR 3 250 000 for France;

(k) EUR 1 100 000 for Italy;

The maximum of

the costs to be reimbursed to the
3.
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

(a) for a bacteriological
test (cultivation)

EUR 5,0 per test;

(b) for the purchase of one

EUR 0,05 per dose;

vaccine dose

(c) for serotyping of relevant
isolates of Salmonella spp.

EUR 20 per test;

(d) for the analysis to verify the
efficiency of the use of
disinfectants

EUR 5,0 per test;

(e) for the culling of a breeding

EUR 3,5 per bird;

bird of Gallus gallus

(l)

EUR 76 000 for Cyprus;

of Gallus gallus

(f) for the culling of a laying bird

EUR 1,5 per bird.

L 322/44

EN

Official Journal of the European Union

2.12.2008

Article 6

Article 7

Classical swine fever and African swine fever

Swine vesicular disease

1.

The programmes for the control and monitoring of:

1.
The programme for the eradication of swine vesicular
disease submitted by Italy is hereby approved for the period
from 1 January 2009 to 31 December 2009.

(a) Classical

swine fever

submitted by Bulgaria, Germany,
France, Luxembourg, Hungary, Romania, Slovenia and
the period from
Slovakia
1 January 2009 to 31 December 2009.

approved for

are hereby

The financial contribution by the Community shall be at
2.
the rate of 50 % of the cost of laboratory tests and shall not
exceed EUR 500 000.

(b) African swine fever submitted by Italy is hereby approved
for the period from 1 January 2009 to 31 December 2009.

Article 8

The financial contribution by the Community shall be at
2.
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
virological and serological tests of domestic pigs and wild boars
and for
the programmes submitted by Bulgaria, Germany,
France, Romania and Slovakia also at the rate of 50 % of the
costs to be incurred for
the purchase and distribution of
vaccines plus baits for the vaccination of wild boars and, for
Romania, for the vaccination of domestic pigs as well, and shall
not exceed:

(a) EUR 200 000 for Bulgaria;

Avian influenza in poultry and wild birds

1.
The survey programmes for avian influenza in poultry and
wild birds submitted by Belgium, Bulgaria, the Czech Republic,
Denmark, Germany, Estonia,
Ireland, Greece, Spain, France,
Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta,
the Netherlands, Austria, Poland, Portugal, Romania, Slovenia,
Slovakia, Finland, Sweden and the United Kingdom are hereby
approved for the period from 1 January 2009 to 31 December
2009.

The financial contribution by the Community shall be at
2.
the rate of 50 % of the costs to be incurred by each Member
State for the costs of carrying out laboratory tests and a lump
sum for sampling of wild birds, and shall not exceed:

(b) EUR 800 000 for Germany;

(a) EUR 90 000 for Belgium;

(c) EUR 550 000 for France;

(b) EUR 70 000 from Bulgaria;

(d) EUR 100 000 for Italy;

(c)

EUR 60 000 for the Czech Republic;

(e) EUR 350 000 for Hungary;

(f) EUR 5 000 for Luxembourg;

(g) EUR 2 500 000 for Romania;

(h) EUR 30 000 for Slovenia;

(i) EUR 550 000 for Slovakia.

(d) EUR 200 000 for Denmark;

(e)

EUR 500 000 for Germany;

(f)

EUR 7 000 for Estonia;

(g) EUR 60 000 for Ireland;

(h) EUR 70 000 for Greece;

(i)

EUR 350 000 for Spain;

The maximum of

3.
the costs to be reimbursed to the
Member States for the programmes referred to in paragraph 1
shall on average not exceed for an ELISA test EUR 2,5 per test.

(j)

EUR 200 000 for France;

2.12.2008

EN

Official Journal of the European Union

L 322/45

(k) EUR 550 000 for Italy;

(c) HI test for H5/H7

EUR 12 per test;

(l)

EUR 15 000 for Cyprus;

(d) virus isolation test

EUR 30 per test;

(m) EUR 30 000 for Latvia;

(e) PCR test

EUR 15 per test;

(n) EUR 40 000 for Lithuania;

(f) sampling wild birds

EUR 20 per sample.

(o) EUR for 10 000 Luxembourg;

Article 9

(p) EUR 180 000 for Hungary;

(q) EUR 7 000 for Malta;

(r)

EUR 500 000 for the Netherlands;

(s)

EUR 50 000 for Austria;

(t)

EUR 80 000 for Poland;

(u) EUR 200 000 for Portugal;

(v) EUR 400 000 for Romania;

Transmissible spongiform encephalopathies (TSE), bovine
spongiform encephalopathy (BSE) and scrapie

the monitoring of

The programmes for

spongiform encephalopathy (BSE)

1.
transmissible
spongiform encephalopathies (TSE), and for the eradication of
bovine
scrapie
submitted by Belgium, Bulgaria, the Czech Republic, Denmark,
Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus,
Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands,
Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland,
Sweden, and the United Kingdom are hereby approved for the
period from 1 January 2009 to 31 December 2009.

and of

2.
The financial contribution by the Community shall be at
the rate of 100 % of the costs to be incurred by each Member
State referred to in paragraph 1 for carrying out rapid tests and
primary molecular discriminatory tests and at the rate of 50 %
of the cost incurred by each Member State for the compen­
sation to owners for the value of their animals culled and
destroyed in accordance with their BSE and scrapie eradication
programmes and at a rate of 50 % of the cost of the analysis of
samples for genotyping, and shall not exceed:

(w) EUR 55 000 for Slovenia;

(a) EUR 1 850 000 for Belgium;

(x) EUR 50 000 for Slovakia;

(b) EUR 750 000 for Bulgaria;

(y) EUR 35 000 for Finland;

(c)

EUR 920 000 for the Czech Republic;

(z) EUR 280 000 for Sweden;

(d) EUR 1 850 000 for Denmark;

(za) EUR 380 000 for the United Kingdom.

(e)

EUR 8 900 000 for Germany;

The maximum of

the costs to be reimbursed to the
3.
Member States for the tests covered by the programmes shall
on average not exceed:

(f)

EUR 220 000 for Estonia;

(g) EUR 5 400 000 for Ireland;

(a) ELISA test

EUR 1 per test;

(h) EUR 2 000 000 for Greece;

(b) agar gel immune diffusion test EUR 1,2 per test;

(i)

EUR 7 400 000 for Spain;

L 322/46

EN

Official Journal of the European Union

2.12.2008

(j)

EUR 12 600 000 for France;

(k) EUR 4 100 000 for Italy;

(l)

EUR 1 800 000 for Cyprus;

(m) EUR 230 000 for Latvia;

(n) EUR 530 000 for Lithuania;

(o) EUR 105 000 for Luxembourg;

(p) EUR 990 000 for Hungary;

(q) EUR 24 000 for Malta;

(r)

EUR 2 900 000 for the Netherlands;

(s)

EUR 1 150 000 for Austria;

(t)

EUR 3 340 000 for Poland;

(u) EUR 1 300 000 for Portugal;

(v) EUR 1 300 000 for Romania;

(w) EUR 250 000 for Slovenia;

(x) EUR 860 000 for Slovakia;

(y) EUR 750 000 for Finland;

(z) EUR 900 000 for Sweden;

(za) EUR 5 900 000 for the United Kingdom.

3.
The financial contribution by the Community to the
programmes referred to in paragraph 1 shall be for the tests
performed and for the animals culled and destroyed and the
maximum amount shall on average not exceed:

(b) EUR 30 per test, for tests carried out in ovine and caprine
animals referred to in Annex III to Regulation (EC) No
999/2001;

(c) EUR 50 per test, for tests carried out in cervid animals
referred to in Annex III to Regulation (EC) No 999/2001;

(d) EUR 175 per test,

for primary molecular discriminatory
tests carried out as
referred to in point 3.2(c)(i) of
Chapter C of Annex X to Regulation (EC) No 999/2001;

(e) EUR 10 per genotyping test;

(f) EUR 500 per bovine animal;

(g) EUR 70 per culled sheep or goat.

Article 10

Rabies

The programmes for the eradication of rabies submitted
1.
by Bulgaria, Lithuania, Hungary, Austria, Poland, Romania and
Slovakia are hereby approved for the period from 1 January
2009 to 31 December 2009.

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
laboratory tests and for the purchase and distribution of vaccine
plus baits for the programmes, and shall not exceed,

(a) EUR 790 000 for Bulgaria;

(b) EUR 1 100 000 for Lithuania;

(c) EUR 780 000 for Hungary;

(d) EUR 270 000 for Austria;

(e) EUR 4 450 000 for Poland;

(f) EUR 500 000 for Romania;

(g) EUR 470 000 for Slovakia.

(a) EUR 5 per test,

for tests carried out in bovine animals
referred to in Annex III to Regulation (EC) No 999/2001;

The maximum of

3.
the costs to be reimbursed to the
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

2.12.2008

EN

Official Journal of the European Union

L 322/47

(a) for an ELISA test

EUR 8 per test;

(a) EUR 800 000 for Spain;

(b) for a test to detect
tetracycline in bone

EUR 8 per test.

(b) EUR 80 000 for Hungary;

Article 11

Enzootic bovine leucosis

1.
The programmes for the eradication of enzootic bovine
leucosis submitted by Estonia, Lithuania, Malta and Poland are
hereby approved for the period from 1 January to 31 December
2009.

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
laboratory tests and compensation to owners for the value of
their animals slaughtered subject to those programmes, and
shall not exceed:

(c) EUR 2 500 000 for Poland.

The maximum of

the costs to be reimbursed to the
3.
Member States for the programmes referred to in paragraph 1
shall on average not exceed for an ELISA test EUR 1 per test.

CHAPTER II

MULTI-ANNUAL PROGRAMMES

Article 13

Rabies

(a) EUR 15 000 for Estonia;

(b) EUR 20 000 for Lithuania;

(c) EUR 500 000 for Malta;

(d) EUR 800 000 for Poland.

The second year of the multi-annual programmes for the
1.
eradication of
submitted by the Czech Republic,
Germany, Estonia, Latvia, Slovenia, and Finland are hereby
approved
to
the
31 December 2009.

from 1

January

period

rabies

2009

for

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
laboratory tests and for the purchase and distribution of vaccine
plus baits for the programmes and shall not exceed:

The maximum of

3.
the costs to be reimbursed to the
Member States for the programme referred to in paragraph 1
shall on average not exceed:

(a) EUR 600 000 for the Czech Republic;

(b) EUR 325 000 for Germany;

(a) for an ELISA test

EUR 0,5 per test;

(c) EUR 1 000 000 for Estonia;

(b) for an agar gel immune

EUR 0,5 per test;

(d) EUR 1 100 000 for Latvia;

diffusion test

(c) for an animal slaughtered

EUR 375 per animal.

Article 12

Aujeszky’s disease

The programmes for the eradication of Aujeszky’s disease
1.
submitted by Spain, Hungary and Poland are hereby approved
for the period from 1 January 2009 to 31 December 2009.

(e) EUR 370 000 for Slovenia;

(f) EUR 100 000 for Finland.

The maximum of

the costs to be reimbursed to the
3.
concerned Member State for the programmes referred to in
paragraph 1 shall on average not exceed:

2.
The financial contribution by the Community to the
programmes referred to in paragraph 1 shall be at the rate of
50 % of the costs to be incurred by the concerned Member
State for the cost of laboratory tests, and shall not exceed:

(a) for an ELISA test

EUR 8 per test;

(b) for a test to detect
tetracycline in bone

EUR 8 per test.

L 322/48

EN

Official Journal of the European Union

2.12.2008

The amounts to be committed for the following years
execution of
the
these amounts (in

4.
shall be decided in function of
the
programme in 2009. An indication of
euro) is given below:

The maximum of

the costs to be reimbursed to the
3.
Member States for the programmes referred to in paragraph 1
shall on average not exceed:

Member state

2010

2011

2012

(a) for an ELISA test

EUR 0,5 per test;

Czech republic

Germany

Latvia

Finland

Estonia

Slovenia

1 250 000

100 000

1 250 000

1 250 000

350 000

350 000

350 000

Article 14

Aujeszky’s disease

(b) for an agar gel immune

EUR 0,5 per test;

diffusion test

(c) for animals slaughtered

EUR 375 per animal.

The amounts to be committed for 2010 shall be decided
4.
in function of the execution of the programme in 2009. An
indication of these amounts (in euro) is given below:

1.
The second year of the multi-annual programme for the
eradication of Aujeszky’s disease submitted by Belgium is
hereby approved for
the period from 1 January 2009 to
31 December 2009.

(a) EUR 800 000 for Italy;

(b) EUR 55 000 for Latvia;

2.
The financial contribution by the Community shall be at
the rate of 50 % of the cost to be incurred by Belgium of
carrying out laboratory tests and shall not exceed EUR 175 000.

(c) EUR 350 000 for Portugal.

3.
The maximum of the costs to be reimbursed to Belgium
for the programme referred to in paragraph 1 shall on average
not exceed for an ELISA test EUR 1 per test.

Article 15

Enzootic bovine leucosis

1.
The second year of the multi-annual programmes for the
eradication of enzootic bovine leucosis submitted by Italy,
Latvia, and Portugal are hereby approved for the period from
1 January 2009 to 31 December 2009.

2.
The financial contribution by the Community shall be at
the rate of 50 % of the costs to be incurred by each Member
State referred to in paragraph 1 for the cost of carrying out
laboratory tests and compensation to owners for the value of
their animals slaughtered subject to those programmes and shall
not exceed:

(a) EUR 800 000 for Italy;

(b) EUR 55 000 for Latvia;

Article 16

Diseases in aquaculture animals

The multi-annual programme for
the eradication of viral
haemorrhagic septicaemia (VHS) submitted by Denmark and
the programme for the eradication of koi herpes virus disease
(KHV) submitted by Germany are hereby approved for the
period from 1 January 2009 to 31 December 2013.

CHAPTER III

GENERAL AND FINAL PROVISIONS

Article 17

The compensation to the owners for the value of the animals
culled or slaughtered and of the destroyed products shall be
granted within 90 days after the slaughter or culling of the
animal or the destruction of the products or after the presen­
tation of the completed claim by the owner.

Article 9(1),
(2) and (3) of Commission Regulation (EC) No
883/2006 (1) shall apply to compensation payments made
outside of the 90 days.

(c) EUR 350 000 for Portugal.

(1) OJ L 171, 23.6.2006, p. 1.

2.12.2008

EN

Official Journal of the European Union

L 322/49

Article 18

(e)

1.
The expenditure submitted by the Member States for a
financial contribution by the Community shall be expressed in
euro and shall exclude value added tax and other taxes.

2. Where a Member State's expenditure is in a currency other
than the euro, the Member State concerned shall convert it into
euro by applying the most recent exchange rate set by the
European Central Bank prior to the first day of the month in
which the application is submitted by the Member State.

report

for the programmes referred to in Articles 1 to 16, forward
a final
to the Commission in accordance with
Article 24(7)(b) of Decision 90/424/EEC by 30 April
2010 at
the
programme accompanied by justifying evidence as to the
costs paid by the Member State and the results attained
during the period from 1 January 2009 to 31 December
2009;

the latest on the technical execution of

(f)

for programmes referred to in Articles 1 to 16, implement
the programme efficiently;

Article 19

1.
The financial contribution by the Community for the
programmes referred to in Articles 1 to 16 shall be granted
provided that the Member States concerned:

(g) do not, for the programmes referred to in Articles 1 to 16,
submit further requests for other Community contributions
for these measures, and have not previously submitted such
requests.

(a)

implement the programmes in accordance with the relevant
provisions of Community law,
including rules on compe­
tition and on the award of public contracts;

2. Where a Member State does not comply with paragraph
1, the Commission shall reduce the financial contribution by
the Community having regard to the nature and gravity of the
infringement, and to the financial loss for the Community.

(b) bring into force by 1 January 2009 at the latest the laws,
regulations and administrative provisions necessary for im­
plementing the programmes referred to in Articles 1 to 16;

Article 20

This Decision shall apply from 1 January 2009.

(c)

forward to the Commission by 31 July 2009 at the latest
the intermediate technical and financial reports for the
programmes referred to in Articles 1 to 16, in accordance
with Article 24(7)(a) of Decision 90/424/EEC;

Article 21

This Decision is addressed to the Member States.

(d) for the programmes referred to in Article 8, report to the
Commission the positive and negative results of
investi­
gations detected during their surveillance of poultry and
wild birds through the Commission on-line system, every
three months, by forwarding those results within a period of
four weeks following the end of the month covered by the
report;

Done at Brussels, 28 November 2008.

For the Commission

Androulla VASSILIOU
Member of the Commission